{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["26"],"submitter":["Sato A"],"pubmed_abstract":["<h4>Background</h4>Hereditary breast and ovarian cancer (HBOC) is a major type of hereditary cancer. Establishing effective screening to identify high-risk individuals for HBOC remains a challenge. We developed a prototype of a chatbot system that uses artificial intelligence (AI) for preliminary HBOC screening to determine whether individuals meet the National Comprehensive Cancer Network BRCA1/2 testing criteria.<h4>Objective</h4>This study's objective was to validate the feasibility of this chatbot in a clinical setting by using it on a patient population that visited a hospital.<h4>Methods</h4>We validated the medical accuracy of the chatbot system by performing a test on patients who consecutively visited the Kanagawa Cancer Center. The participants completed a preoperation questionna"],"journal":["Journal of medical Internet research"],"pagination":["e48914"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11635313"],"repository":["biostudies-literature"],"pubmed_title":["Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study."],"pmcid":["PMC11635313"],"pubmed_authors":["Sato A","Haneda E","Narimatsu H","Hiroshima Y"],"additional_accession":[]},"is_claimable":false,"name":"Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study.","description":"<h4>Background</h4>Hereditary breast and ovarian cancer (HBOC) is a major type of hereditary cancer. Establishing effective screening to identify high-risk individuals for HBOC remains a challenge. We developed a prototype of a chatbot system that uses artificial intelligence (AI) for preliminary HBOC screening to determine whether individuals meet the National Comprehensive Cancer Network BRCA1/2 testing criteria.<h4>Objective</h4>This study's objective was to validate the feasibility of this chatbot in a clinical setting by using it on a patient population that visited a hospital.<h4>Methods</h4>We validated the medical accuracy of the chatbot system by performing a test on patients who consecutively visited the Kanagawa Cancer Center. The participants completed a preoperation questionna","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2025-04-03T23:26:10.957Z","creation":"2025-04-03T23:26:10.957Z"},"accession":"S-EPMC11635313","cross_references":{"pubmed":["39602801"],"doi":["10.2196/48914"]}}